Fresh2 Group (Fresh2 Group) Debt-to-Equity : 0.00 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Fresh2 Group Debt-to-Equity?

Fresh2 Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.02 Mil. Fresh2 Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.01 Mil. Fresh2 Group's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $12.92 Mil. Fresh2 Group's debt to equity for the quarter that ended in Jun. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fresh2 Group's Debt-to-Equity or its related term are showing as below:

During the past 6 years, the highest Debt-to-Equity Ratio of Fresh2 Group was 2.79. The lowest was -92.96. And the median was 0.00.

FRES's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.145
* Ranked among companies with meaningful Debt-to-Equity only.

Fresh2 Group Debt-to-Equity Historical Data

The historical data trend for Fresh2 Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresh2 Group Debt-to-Equity Chart

Fresh2 Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

-1.16

-2.42

2.79

-7.51

-0.90

Fresh2 Group Quarterly Data
	Dec17	Sep18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Debt-to-Equity	Get a 7-Day Free Trial														2.30	1.38	-2.65	-0.90	-

Competitive Comparison of Fresh2 Group's Debt-to-Equity

For the Biotechnology subindustry, Fresh2 Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresh2 Group's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fresh2 Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fresh2 Group's Debt-to-Equity falls into.

Fresh2 Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fresh2 Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.832	+	0.934)	/	-1.962
	=	-0.90

Fresh2 Group's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.023	+	0.005)	/	12.92
	=	0.00

Fresh2 Group (NAS:FRES) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fresh2 Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fresh2 Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresh2 Group (Fresh2 Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fresh2 Group Ltd (NAS:FRES) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0UC0:Germany

Address

650 5TH Avenue, Street 2416, NEW YORK, NY, USA, 10019-6108

Website

https://www.fresh2.co

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.